Article
Mechanisms of chaperone suppression of polyglutamine disease: selectivity, synergy and modulation of protein solubility in Drosophila.
Human molecular genetics - 22 Nov 2000
Chan H Y, Warrick J M, Gray-Board G L, Paulson H L, Bonini N M
Abstract excerpt
At least eight dominant human neurodegenerative diseases are due to the expansion of a polyglutamine within the disease proteins. This confers toxicity on the proteins and is associated with nuclear inclusion formation. Recent findings indicate that molecular chaperones can modulate polyglutamine pathogenesis, but the basis of polyglutamine toxicity and the mechanism by which chaperones suppress neurodegeneration...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
